A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

INTRODUCTION: Two standard single-agent chemotherapy treatments (docetaxel and pemetrexed) were combined in this trial and administered as second-line treatment in patients with non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the safety and feasibility of combining docetaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroeber, Vinzenz, Nagel, Sylke, Schuette, Wolfgang, Blankenburg, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: July, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130819/
https://www.ncbi.nlm.nih.gov/pubmed/25126073
http://dx.doi.org/10.1159/000365323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130819/
https://www.ncbi.nlm.nih.gov/pubmed/25126073
http://dx.doi.org/10.1159/000365323

Ejemplares similares